Links
- Federal judge nixes FDA’s lab-developed test rule.
- Is AI a solution to the hospital staffing crisis?
- PBM price floor in Montana?
- AI finds new uses for old drugs.
- Measles comes to California (map)
Why were physicians against smallpox variolation in the Middle Ages? – Healthcare Economist
From the Conversation with Tyler podcast with Sheilagh Ogilvie:
: Historically, there was another reason, which was the medical guilds — the equivalent of the American Medical Association, only.
The Elasticity of Pharmaceutical Innovation – Healthcare Economist
That is the title of a new USC white paper by Darren Filson, Karen Van Nuys, Darius Lakdawalla and Dana Goldman with the subtitle “How Much Does Revenue Drive New Drug Development?”.
What is the Critical Medicines Act? – Healthcare Economist
On Tuesday (11 March 2025) the European Commission presented the draft of its new Critical Medicines Act (CMA). The Science Media Centre España writes that the CMA’s objective is:
…to address.
NHS England will be abolished – Healthcare Economist
As reported by the BBC:
NHS England will be abolished and brought under “democratic control” in an attempt to cut bureaucracy and duplication, Sir Keir Starmer has announced.
The organisation, which oversees.
Number of US caregivers increases form 18 to 24 million – Healthcare Economist
That is according to a paper by Wolff et al. (2025). They use 2011-2022 data from the National Health and Aging Trends Study (NHATS) linked to data from.
What is Project IDEATE? – Healthcare Economist
How best can you design an outcomes based agreement (OBA)? What are the key factors to consider? Project IDEATE is a “cross-disciplinary collaboration between National Health Service (NHS) Wales, industry and.
Quotation of the Day
There is nothing so useless as doing efficiently that which should not be done at all.
Peter Drucker
Disclaimer :
This article is solely for informational purposes, any medical information.
Links
- Sarah Emond on Prescription for Better Access.
- “Nothing will have more impact on workers’ comp than significant cuts to Medicaid.”
- “So one can only assume that we’re not picking flu strains this year.”
- SLR: Palliative.
Value-Based Pricing for Drugs With Uncertain Clinical Benefits – Healthcare Economist
This is the title of a recent paper by Jiao et al. (2025). Previous studies (e.g., Goldman et al. 2013, Goldman et al. 2023) have argued for a 3-part pricing model..